Found 8 matching trials
Cadonilimab Plus CapeOX as First-Line Treatment for Advanced GC/GEJC With High TMEscore
PHASE2This is a single-arm, open-label, multi-center clinical study to evaluate t...
Location
Nanfang Hospital, Southern Medical University
Short-course Radiotherapy Followed by Tislelizumab + CapeOX in the Treatment for Locally Advanced Rectal Cancer
PHASE2This study is a single-center, prospective, open-label, randomized controll...
Location
Fourth Hospital of Hebei Medical University
SBRT Combined With CAPEOX, Bevacizumab, and PD-1 Inhibitor for the Treatment of RAS-Mutant, MSS-Type, Unresectable Metastatic Colorectal Cancer.
PHASE2SBRT Combined with CAPEOX, Bevacizumab, and PD-1 Inhibitor in RAS-Mutant, M...
Location
Multiple Locations
A Combination Therapy Including Anti-PD-1 Immunotherapy in MSS Rectal Cancer With Resectable Distal Metastasis
PHASE2Although patients with locally advanced rectal cancer and resectable liver/...
Location
Fudan University Shanghai Cancer Center
Adjuvant PD-1 Blockade for High-risk Stage-II DMMR/MSI-H Colorectal Cancer
PHASE3This open-label phase III trial investigates the efficacy of two cycles of ...
Location
Dept. of Colorectal Surgery, Sun Yat-sen University Cancer Center. Yuexiu District, Dongfeng East Road 651
Lenvatinib Plus Tislelizumab and CapeOX as First-Line Treatment for Advanced GC/GEJC With Positive PD-L1 and Low TMEscore
PHASE2This is a multicenter, prospective, phase II clinical study to evaluate the...
Location
Nanfang Hospital, Southern Medical University
HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer
PHASE2The purpose of this clinical trial is to learn the safety and efficacy of H...
Location
Daping Hospital, Third Military Medical University
Neoadjuvant Fruquintinib Plus Tislelizumab Combined With mCapeOX Versus CapeOX for Mid-high pMMR/MSS Locally Advanced Rectal Cancer
PHASE2The goal of this clinical trial is to learn if neoadjuvant Fruquintinib and...
Location
Peking University Cancer Hospital & Institute